Paracrine- and cell-contact-mediated immunomodulatory effects of human periodontal ligament-derived mesenchymal stromal cells on CD4+ T lymphocytes

Christian Behm,Oliwia Miłek,Xiaohui Rausch-Fan,Andreas Moritz,Oleh Andrukhov
DOI: https://doi.org/10.1186/s13287-024-03759-4
2024-06-01
Stem Cell Research & Therapy
Abstract:Mesenchymal stromal cells (MSCs) isolated from the periodontal ligament (hPDL-MSCs) have a high therapeutic potential, presumably due to their immunomodulatory properties. The interaction between hPDL-MSCs and immune cells is reciprocal and executed by diverse cytokine-triggered paracrine and direct cell-to-cell contact mechanisms. For the first time, this study aimed to directly compare the contribution of various mechanisms on this reciprocal interaction using different in vitro co-culture models at different inflammatory milieus.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?
This paper aims to explore the bidirectional immunomodulatory effects between human periodontal ligament - derived mesenchymal stromal cells (hPDL - MSCs) and CD4+ T lymphocytes, especially the interaction mechanisms in different cell co - culture models and inflammatory environments. Specifically, the study compared three different models, namely the indirect co - culture model (using inserts with a pore size of 0.4 μm), and the direct co - culture model (with or without inserts). After co - culturing untreated, interleukin - 1β (IL - 1β) - or tumor necrosis factor - α (TNF - α) - treated hPDL - MSCs with activated CD4+ T lymphocytes for five days, the proliferation, survival rate and cytokine secretion of CD4+ T lymphocytes were observed, as well as the gene expression changes of soluble and membrane - bound immunological mediators in hPDL - MSCs after co - culture. The main objectives of the study are: 1. To compare the effects of hPDL - MSCs on the proliferation, survival and cytokine secretion of CD4+ T lymphocytes under different co - culture models. 2. To explore the differences in immunomodulatory mechanisms between hPDL - MSCs and CD4+ T lymphocytes under different inflammatory conditions (i.e., untreated, IL - 1β - treated and TNF - α - treated). 3. To evaluate the influence of the co - culture model type on the immunomodulatory ability of hPDL - MSCs, especially to analyze the changes in the gene expression of immunological mediators in hPDL - MSCs in different models. Through these studies, the authors hope to reveal the specific mechanisms of the interaction between hPDL - MSCs and CD4+ T lymphocytes and how this interaction is affected by the inflammatory environment, thereby providing a theoretical basis for future immunomodulatory therapies based on hPDL - MSCs.